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The demand for animal protein for human consumption is currently on the rise 
and is largely supplied by livestock farms. This activity requires high-quality feeds for 
the animals with high protein content, which should contain not only necessary nutrients 
but also complementary additives to keep animals healthy and favor growth. Some of 
the most utilized growth-promoting additives include hormones, antibiotics, ionophores 
and some salts.  
 Although these additives promote increasing in growth, on the other hand their 
improper use can result in adverse effects on the animal and final consumer. In the case 
of antibiotics it can lead for example to resistance on pathogenic bacteria.  
Diet, stress, antibiotics and modern husbandry practices have been identified as 
factors capable of affecting animal health and animal growth performance. However, it 
is known that antibiotics have indirect adverse side effects with implications for human 
health. 
In this contest, probiotics, organics acids and food supplements have deserved 
considerable attention of researchers as a possible alternative to the substitution of the 
traditional promoters of growth. 
   
1.1 SWINE 
Pork meat is the most consumed animal protein in the world. In 1999, pork 
producers throughout the world produced 88.4 million tones of meat, in the following 
order, according to volume of production: Asia, EU, Americas and Africa + Australasia, 
with 53.2%, 28.9%, 16.3% and 1%, respectively. The worldwide consumption of pork, 
based on a population of 6.0 billion people, can be estimated at 14.7 kg/person, which 
makes it the most consumed meat in the world.  The consumption of pork in Brazil can 
be estimated at 11 kg/person/year. The pig production industry in the south of Brazil 
can be considered the most technical pig production industry in South America, with 
good productivity rates, placing our country among the world's seven largest producers, 
with 1.75 tones of pork per year (Silveira, 2005). 
One of the biggest problem of swine production is the mortality that is around 
20%, especially after weaning. Precociously weaned pigs precociously experience 
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nutritional and environment stress with limited digestion capacity (due to insufficient 
production of chloride acid and digestive enzymes as amylase, lipase and tripsin 
pancreatic and also to the sudden alteration in the composition of the diet). 
Immunological problems can also affect the performance after weaning, since its 
immunity is not completely effective yet (APCS, 2005). 
Diarrhea is the main cause in 41% of the deaths and it contributes significantly 
for the decrease in performance and health of swines (Larpent et al., 1994). According 
to Jonsson (1992), the main etiological agent of diarrhea in swines is the 
enterotoxigenic bacteria Escherichia coli. Infection rates are reported to vary between 
31 in U.S.A. and 82 cases in Australia. 
During the first three weeks of age (wean period included), swines are highly 
susceptible to the diarrhea. Escherichia coli bacteria adhere to the corrugated mucosal 
folds of the host intestine and produce enterotoxins that stimulate enterocit cells to 
pump liquid into the lumen, increasing intestinal contractions and resulting diarrhea. 
 Neomycin antibiotic has largely been used for colibacilose treatment (OURO 
FINO ANIMAL HEALTH, 2005), in which it acts inhibiting protein synthesis of the 
microorganism. This antibiotic binds to bacterial ribosome provoking the incorrect 
reading of the genetic code and consequently, defective amino acids are incorporated 
into the polypeptide chain. The defective protein formed is then used by the metabolism 
of the bacterium, resulting in its death. 
 This aforementioned antibiotic suffers little adsorption although it presents 
intense activity in the host intestine lumen. This antibiotic is specific for intestinal 
infections and afterwards it is eliminated with feces, in an active form.   
  E. coli has high ability to develop resistance to drugs due to its genetic 
exchanges from generation to generation.  The mutational exchange that confers 
resistance can simultaneously modify the virulence factors and affect the pathogenicity 
of the microorganism. E. coli carries R-plasmids which regulates the resistance to drugs. 
Although this resistance happens, in the last 25 years the ratio of enteric bacteria that 
load plasmids for resistance to a multitude of drugs has increased quite slowly 
(Saldarriaga et al., 2000). 
Swine is monogastric and harbors a complex bacterial flora in its intestine tract 
that basically suppresses undesirable bacteria. The predominant bacteria of this 
microflora are mainly those lactic acid types such as Lactobacillus sp. and 
Streptococcus sp. (Rojas et al., 2002). 
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Administration of antimicrobial agents may disturb the microbial flora. This and 
other factors that may lead to the microflora imbalance may directly reflect in the host 
heath. The use of an improper antibiotic for example can cause a stress of any nature 
that will allow pathogenic microorganisms to install and multiply. 
 
1.2 PROMOTERS OF GROWTH IN THE SWINECULTURE 
The gastrointestinal tract has the function to convert ingested food in necessary 
nutrients to the growth, maintenance, production and reproduction. The gastrointestinal 
tract is extremely exposed to action of exogenous agents that may be ingested with 
foods. To assure that the food will be properly ingested and converted into nutrients, 
some chemical additives are added to the diet. Some of them such as antimicrobials, 
acid substances (formic acid, ascetic, citric, lactic), probiotics and enzymes are used to 
promote the animal growth (Roth, 2005).  
Modern growth-promoters can improve the animal performance by using low 
dosages without increasing resistance and crossovers with other promoters. They are 
non-toxic, non-mutagenic and consequently keep the normal gastrointestinal flora on 
balance. In addition, these promoters are biodegradable and then they prevent 
environmental pollution (Lancini, 1994). 
  
1.3 PROBIOTIC 
 The term probiotic is a relatively new word that means “for life” and it is 
currently used to nominate those bacteria associated with benefit effects for humans and 
animals. The original observation of the positive role played by some selected bacteria 
is attributed to Eli Metchnikoff, a Russian born scientist who won the Nobel Prize in the 
beginning of the last century when he worked at the Pasteur Institute. He suggested that 
"The dependence of the intestinal microbes on the food makes it possible to adopt 
measures to modify the flora in our bodies and to replace the harmful microbes by 
useful microbes"(FAO/WHO, 2001). 
At this time Henry Tissier, a French pediatrician, observed that children with 
diarrhea had in their stools a low number of bacteria characterized by a peculiar Y 
shaped. In contrast, these “bifid” bacteria were abundant in healthy children. Afterwards 
he suggested that these bacteria could be administered to patients with diarrhea to help 
to restore a healthy intestine flora. 
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In order to redefine the microbial nature of probiotics, Fuller (1989) point out 
the word as "A live microbial feed supplement that beneficially affects the host animal 
by improving its intestinal balance". More recently, but probably not the last, a new 
definition for probiotic is given by Guarner and Schaafsma (1998) as being "live 
microorganisms that, when consumed in adequate amounts, confer a health effect on the 
host". 
Lactobacilli are the most common bacteria used as probiotics in animal feeds 
and human foods. The use in animal feed is under regulations especially concerning to 
the additives.   
Members of Lactobacillus and Bifidobacterium genera are also largely 
employed, but not exclusively as probiotic microorganisms. The number of probiotic 
foods available to the consumer is highly increasing in number. However, some 
ecological considerations for the intestine flora has to be taken into account. It is 
necessary to understand more about the relevance of probiotic food concept for humans. 
When incorporated to the food as part of the elaboration or as additive, 
probiotics generate a functional food, i.e., it presents particular characteristics, 
nutritional or not, that promote a physiological effect on the organism in a positive way 
improving the traditional nutrition (Gonzaález-Martínez et al., 2001). 
Health benefits by probiotics use include: the relief of symptoms of lactose 
intolerance, enhancement of the immune system, reduction in duration of diarrhea 
caused by rotavirus, decrease of faecal bacterial enzyme activity and mutagenicity, 
prevention of recurrence of supercial bladder cancer, and prevention of atopic diseases 
(Naidu, Bidlack, & Clemens, 1999; Kalliomaki et al., 2001). 
Probiotic lactic acid bacteria are commercialized mainly as food supplements for 
daily use (Heller, 2001). Currently, probiotic milk drinks and yogurts are manufactured 
in different ways. Bacteria can be added to fresh milk without any fermentation (for 
instance, the sweet AB Milk®), or the milk can be fermented with the probiotic bacteria 
(for instance Yakult®). A third type of product is the mild yogurt added Streptococcus 
thermophilus and a probiotic Lactobacillus used as strain starters. The probiotic 
Lactobacillus, more often L. acidophilus, replaces L. delbrueckii subsp. bulgaricus that 
is the normal starter (together with St. thermophilus) for the manufacture of yoghurt 
(Heller, 2001). The advantage of using those two combined bacteria is that the probiotic 
bacterium may produce functional metabolites such as bacteriocins during fermentation. 
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The volume of fermented broth represents more than 95% of the biomass 
production. This fermented broth contains functional metabolites, not fermented sugar 
and mineral salts. In the conventional process this broth is considered a residue and 
generally is discarded. Due to the high concentration of the organic material, the broth 
naturally presents Biochemical Oxygen Demand/Chemical Oxygen Demand 
(BOD/COD) in 20.000 mg O2/L. It may cause an overload in the station of treatment of 
the industry. The international literature is scarce in references about valuation and/or 
the use of this bioresidue. The development of a simple and low cost technology process 
to use this bioresidue is necessary to facilitate the transformation of it in new products.  
 
1.4 LACTIC ACID BACTERIA 
 Lactic acid bacteria (LAB) are Gram-positive, catalyze-negative, oxidase 
negative and non-sporulating microaerophilic bacteria whose lactate is the main 
fermentation product from carbohydrates. The lactic acid bacteria comprise both types 
cocci (e.g. Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Tetragenococcus, 
Stretococcus, Enterococcus) and rods (Lactobacillus, Carnobacterium, 
Bifidobacterium). Many of these lactic acid bacteria are generally recognized for their 
contribution to the flavor and aroma developed and to spoilage retardation (De Vuyst et 
al., 1994). Therefore, the traditional use of these microrganisms in the fermentation of 
foods and beverages has resulted in their application in many starter cultures currently 
involved in the fermentation of a wide variety of agricultural raw materials such as 
milk, meat, fruit, vegetables and cereals (Buckenhüsk, 1993). The lactic acid bacterial 
strains present in these starter cultures contribute to the organoleptic properties and the 
preservation of the fermented products by in situ production of antimicrobial substances 
such as lactic acid and acetic acid, hydrogen peroxide and bacteriocins (Vandenbergh, 
1993). Because of the general tendency to decrease the use of chemical additives, such 
natural inhibitors could replace the use of chemical preservatives such as sulfur dioxide, 
benzoic acid, sorbic acid, nitrate and nitrite. For this reason, bacteriocins produced by 
lactic acid bacteria may be very promising as biological food preservatives in future 
food preservation (Lewus et al., 1991). Some bacteriocins produced by LAB, such as 
nisin, inhibit not only closely related species but are also effective against food-borne 
pathogens such as Listeria monocytogenes and many other gram-positive spoilage 
microrganisms (Tagg et al., 1976). For this reason, bacteriocins have attracted 
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considerable interest for use as natural food preservatives in recent years, which has led 
to the discovery of an ever increasing potential ‘arsenal’ of these protein inhibitors. 
Undoubtedly, the most extensive studies are concentrated in the bacteriocin 
nisin, which has gained widespread application in the food industry. Bacteriocin is FDA 
(Food and Drug Administration) and GRAS (Generally Recognized as Safe) approved. 
For instance, Lactococcus lactis is largely used as a food additive in many countries, 
particularly for cheese process, dairy products and canned foods (Delves-Broughton, 
1990). An alternative approach to introduce bacteriocins to food is the use of live cell 
cultures that produce bacteriocins in situ in the food.  
Furthermore, certain lactic acid bacteria, especially some lactobacilli and 
bifidobacteria, are believed to play a beneficial role in the gastro-intestinal tract 
(Marteau et al., 1993). It is worth noticing that Lactobacilli are also potentially useful as 
carriers for oral immunization. Once orally administered lactobacilli trigger both a 
mucosal and systemic immune reaction against epitopes associated with these 
organisms (Norton et al., 1997). 
The lactic acid bacteria are able to grow in a range of acid band of pH and in 
presence of organic acids. The mechanism of tolerance to the acidity is not completely 
understood, but one believes that passive diffusion occurs and the intracellular 
accumulation reduces pH affecting the membrane permeability (Mcdonald et al., 1990). 
The production of facts acids in the plasmatic membrane of the bacteria determines its 
resistance to stress caused for the acids.  Therefore, organic acid contributes in a way 
for the inhibition of the microrganism growth by increasing energy consumption that 
keeps the homeostasis of pH (Gonzalo et al., 1998). 
 
1.5 ORGANIC ACIDS 
The way that organic acid works is attributed by the direct reduction of the 
substrate pH. The explanation is related to the reduction of the internal cell pH for 
ionization of acids that do not dissociate or for the transport interruption of the substrate 
due to the permeability alteration of the cell membrane. This transport inhibition of 
substrate occurs since organic acid can inhibit NADH oxidation eliminating 
supplements of reduction agents in the electron transport system (Beuchat et al., 1989). 
Organic acids are related to physiological effects with implications to the immune 
system, empting gastric content, intestinal motilities, and water and mineral absorption, 
especially calcium. Formiate is important for metabolism on the transport of substances 
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that contain carbon generated mainly during the amino acid metabolism. Formic acid is 
an efficient acidificant compound that presents independent antimicrobial action of pH 
and inhibits descarboxilases and porfirinics enzymes such as catalase. The antimicrobial 
action of the lactic acid is relatively small, acting mainly against anaerobic bacteria. Its 
antimicrobial action is more related to the reduction of pH (Lück, 1981). 
 
1.6 BACTERIOCINS 
Bacteriocins are proteinaceous compounds produced by bacteria, both Gram 
positive and Gram-negative, and they are active chiefly against closely related bacteria 
(Tagg et al., 1976). The discovery of bacteriocins dates back to 1925, when E. coli V 
was shown to produce an antimicrobial compound active against E. coli F. These 
antimicrobial substances produced by E. coli were named colicins and 17 different 
types, based on their adsorption, were later reported. 
Like the colicins (25–90 kDa, produced by E. coli and active against other 
Enterobacteriaceae) and microcins (<10 kDa, produced by Enterobacteriaceae and 
active against other Gram-negative bacteria), the bacteriocins produced by Gram-
positive bacteria were defined as proteinaceous compounds that kill only closely related 
species (Jack et al., 1995).  Although it is true for the majority of compounds, it is now 
evident that bacteriocins produced by lactic acid bacteria display bactericidal activity 
beyond species that are closely related (Klaenhemmer, 1993). The first report of 
production of a bacteriocin produced by lactic acid bacteria was in 1928 by Rogers. The 
substance was determined as a polypeptide and subsequently named nisin (Mattick et 
al., 1947). Since that time, bacteriocin field has expanded exponentially and now 
bacteriocins produced by all genera of the lactic acid bacteria have been reported. 
Bacteriocin production has been widely found among strains of L. acidophilus complex 
isolated from the intestinal tract (Itoh et al., 1995). In contrast, information about 
bacteriocin production by strains of L. casei complex remains scarce (Cuozzo et al., 
2000). 
The majority of bacteriocins from lactic acid bacteria have been characterized 
according to the early definition of a proteinaceous inhibitor, estimation of their 
molecular mass, and determination of their inhibition spectrum. Recent developments in 
biochemical and molecular biology have improved the characterization of many 
compounds working to elucidate their genetic organization, structures and mode of 
action. Despite their heterogeneity, bacteriocins produced by lactic acid bacteria were 
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subdivided into three distinct classes based on these genetic and biochemical 
resemblances: Lantibiotics (class I); Small, Heat-Stable, Non-Lanthionine containing, 
Membrane-Active Peptides (class II) and Large Heat-Labile Proteins (class III)  (Nes et 
al., 1996). 
The class I bacteriocin, nisin, and some of the class II bacteriocins have been 
shown to be membrane-active peptides that destroy the integrity of the cytoplasmic 
membrane via the formation of membrane channels (Figure 1). In doing so, they alter 
the membrane permeability and therefore cause leakage of low molecular mass 
metabolites or dissipate the proton motive force, thereby inhibiting energy production 
and biosynthesis of proteins or nucleic acids. Most bacteriocins produced by lactic acid 
bacteria display a bactericidal effect on the sensitive cells, all or not resulting in cell 
lysis (Bhunia et al., 1991; Sahl, 1991). On the other hand, other bacteriocins, such as 
lactocin 27, leucocin A and leuconocin S have been reported to act bacteriostatically. 
However, the designation of lethal versus static effect can be dependent upon aspects of 
the assay system, including the number of arbitrary units, the buffer or broth, the purity 
of the inhibitor, and the indicator species and cell density used (De Vuyst et al., 1994). 
The mode of action of numerous bacteriocins has been reported and, therefore, only a 
few of them, representing the different classes are described in this section. 
 
FIGURE 1 - Barrel-stave poration complexes proposed for class II bacteriocins. 
(Klaenhammer, 1993) 
 
The class IAI lantibiotic nisin was shown to form ion-permeable channels in the 
cytoplasmic membrane of susceptible cells, resulting in an increase in the membrane 
permeability, disturbing the membrane potential and causing an efflux of ATP, amino 
acids, and essential ions such as potassium and magnesium. Ultimately, the biosynthesis 
of macromolecules and energy production are inhibited resulting in cell death. Nisin 
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does not require a membrane receptor but requires an energized membrane for its 
activity, which appeared to be dependent on the phospholipid composition of the 
membrane (Sahl, 1991). 
 The class IIA pediocins PA-1/AcH and JD were reported to exhibit their 
bactericidal action at the cytoplasmic membrane and to cause a collapse of the pH 
gradient and proton motive force (Christensen et al., 1992). As for the mechanism of 
action of the class III bacteriocins, it still remains to be elucidated.  
Many of the bacterial metabolic pathways are induced by various extracellular 
stimuli. Those environmental conditions are sensed and signaled through, by means of 
signal transduction systems. Many of these systems consist of two components, a 
sensor, often located in the cytoplasmic membrane and a cytoplasmic response regulator 
(Parkinson et al., 1992). They are, therefore, generally called two-component systems. 
The environmental sensor acts as a histidine protein kinase (HPK) and modifies the 
response regulator (RR) protein, which in turn triggers an adapting response, in most 
cases by gene regulation. Most histidine protein kinases consist of an N-terminal 
sensory domain and a cytoplasmic C-terminal transmitter. These findings could then 
result in the following hypothetical model for bacteriocin biosynthesis (Figure 2).  
Firstly an inducing signal activates, via the two-component signaling pathway, 
the promoters responsible for the expression of the operons involved in bacteriocin 
production. In the case of nisin, production and immunity have shown to be auto 
regulated. Transcription results in the concerted production of the proteins constituting 




FIGURE 2 - A conceptual maturation pathway for nisin is given as a 5-step process. A 
two component signal transduction system induces transcription (step 1). Translation 
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results in an inactive unmodified precursor peptide (step 2). The leader peptide is 
proposed to play a role in targeting of the precursor to a membrane-located modification 
complex (step 3). Dehydration and lanthionine and dehydro-lanthionine formation (step 
4) is followed by extracellular processing and secretion (step 5). (De Vos et al., 1995) 
 
1.7 ANTIBIOTIC 
 The antibiotics are chemical composites used to control infectious organisms.  
Initially they were employed on therapeutic usages and later they became widely used 
to prevent and promote animal growth. It can guarantee high rates of productivity with 
reduction in mortality and morbidity and maintain the animal welfare. Thereby, 
antibiotics use is essential for the current systems of production. 
Although the relation that associates the antibiotic use in the units of animal 
production and the development of resistance and its transference to humans is not 
clear, some epidemiological studies suggest that the consumption of animal derivatives 
is a possible way of pathogenic bacteria acquisition. These evidences have led 
international organizations on human and animal health to recommend prudence for 
antibiotics use. 
According to Padilha (2003), the bacterial resistance has been controlled due to 
great demand in the development of new composite families or simply by modifying 
already existing composites.  
European countries were the first to establish programs for controlling 
antibiotics use in animal production (Wegener et al., 1997). In the United States, the 
"National Program of Monitoring of the Antimicrobial Resistance" has started in 1996 
as a resulting collaboration among institutes such as the Center for Disease Control 
(CDC), Food and Drug Administration (FDA) and the Department of Agriculture. This 
program was responsible for modifications on the antimicrobial susceptibilities status of 
zoonotic enteric-pathogens in humans and animals (illness and healthful) and in 
carcasses of animals. In January 1999, the FDA approved a regulation to vanish the use 
of the majority of antibiotics that promotes animal growth. 
In Brazil, the use of cloranfenicol and nitrofuran in animals whose meat is 
destined to human consumption is prohibited by the Ministry of Agriculture. The 
antibiotics, which use is still allowed, will be forbidden from January of 2006. 
Consequently, an enormous demand for natural promoters of animal growth has been 





The purposes of the present work were to isolate and to characterize probiotic 
bacteria and to check the potential use of fermented broth produced by probiotic 
bacteria during the biomass formation in order to develop a new biopromoter for the 
animals (pigs) and: 
- Determine the gain of suckling pig weight; 
- Check the feed consumption; 
- Estimate the feed conversion; 
- Compare the action of the natural biopromoter with the probiotic in the fist 
weeks of pigs life; 
It is important to notice that this biopromoter was adsorbed in natural support 
sugarcane bagasse, the residue of milled cane. 
 
3 MATERIAL AND METHODS 
 
3.1. MICRORGANISMS ISOLATION 
The microorganisms were isolated from healthy swine never treated by 
antibiotics. Immediately after the pigs were slaughtered, microbial flora was collected 
from stomach, and from small and large intestine, places where a great number of 
bacteria from Lactobacillus genus are found. (Pancheniak, 2005). Samples were diluted 
and distributed, according to the pour plate technique, into plates with MRS agar (Difco 
Laboratories, Richmond, CA, USA). The plates were incubated for 48 hours at 37 °C  
(Reque et al., 2000).  
 
3.2. MICRORGANISM CHARACTERIZATION 
 
3.2.1. Biochemistry and Physiology Characterizations 
 Biochemistry and Physiology characterizations followed Pancheniak (2005) 
where the method is based on the following exam types:   
• Morfology and optical microscope ; 
• Gram stain ; 
• Fermentation in different carbon sources (API 50 CHL, BIOMËRIEUX) ; 
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3.2.2. Molecular Identification 
 The genotype profile for the isolated lactic bacteria were analyzed and compared 
to standard strains. The microbial DNA was amplified using RAPD-PCR technique 
(Random Amplification of Polymorphic DNA-Polymerase Chain Reaction). 
 
3.2.2.1. DNA Extraction from Lactic Bacteria 
Genomic DNA was extract from overnight cultures. The method of DNA 
extraction was performed in four steps: cellular lysis, deproteinization, precipitation and 
quantification of the extracted DNA. 
Cellular lysis – lysis incubation was performed for 30 min at 55 °C using 500 µL 
of lysis buffer (Tris-HCl 10mM pH 8,0; EDTA 1mM; SDS - Sodium Dodecyl Sulfate 
5%). Three cycles of frost (-196 °C/5min) and defrost (37 °C/5min) were made. 
Afterwards, samples were digested by 20 mg/mL of Proteinase K for 30 min at 55 °C 
and RNAase (20mg/mL) for 1hour at 37 °C. 
Deproteinization – proteins were eliminated by 03 phenol extractions followed 
by 01 extraction adding phenol/chloroform/isoamyl alcohol (25:24:1) and 01 addidional 
step in chloroform (removes trace phenol). Each extraction was followed by 
homogenization and centrifugation at 14,000g for 5 min at 20 °C. DNA was always 
kept in the aqueous phase.  
Precipitation – 10% of final volume of sodium acetate (3M) and two volumes of 
cold ethanol were added to the last upper aqueous phase placed in fresh tube. This 
mixture was kept for 1 hour at -70 °C. After centrifugation at 14,000g at 4 °C, the 
precipitated DNA was washed twice with 70% ethanol. The DNA was dried for 10 min 
in 37°C oven to allow ethanol evaporation, and then, the pellet was rehydrated in 100 
µL of ultra pure water.  
DNA dosage – the last step of DNA purification was to verify the purity and 
determine DNA concentration. DNA samples were quantified by agarose gel 
electrophoresis (0.8% agarose) and by UV spectrometer. 
  
3.2.2.2. RAPD Technique 
Amplification was carried out in 25µL reaction volume by thermocycler with a 
hot bonnet lid. Seven different primers (M13, M14, COC, A2, A3, A9 e A10) were 
singly employed in seven series of amplifications (Annex 1). To prevent evaporation 
25µL of mineral oil was added to each reaction tube. 
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Amplification products were resolved by electrophoresis in 1.6% (w/v) agarose 
TAE (40mM tris/acetate, 10mM EDTA pH8.0) gels stained with ethidium bromide and 
photographed.  
Numerical Analysis of the patters were performed by Vilber Lourmat® 
software. Comparisons of RAPD-PCR patters were made using Jaccard Coefficient and 
unweight pair group method using arithmetic averages (UPGMA).    
     
3.3. MICROORGANISM SELECTION 
The probiotic bacterium used in the biopromoter study was from strain P01-001. 
This bacterium was isolated from swine intestine. The strain was subcultured 
anaerobically in customized brown sugarcane (sugarcane brown sugar medium) for 24 
hours at 36 °C. For the stock culture it was centrifuged (7.000 g at 4°C for 20 min), 




  The biomass production was carried out in customized 3% brown sugarcane 
(sugarcane brown sugar medium) and 1% yeast extract. This medium was sterilized at 
1210C for 20 min. To obtain a fresh culture, strains were grown in 50 ml of the medium 
that was used during the fermentation. The transfer volume was 10% (v/v), and the 
incubation was at 370C for 24 hours. 
 
3.5. FERMENTOR-SCALE STUDIES 
 Fermentation was carried out in a 5 L bioreactor with a working volume of 4 L. 
The fermentation media was sugarcane brown sugar 3% and yeast extract 1% medium 
at initial pH 6.5. The pH was not kept constant and the fermentation medium was 
sterilized in situ. The fermentation temperature was kept constant at 37°C without 
agitation. The kinetic of the bacteria growth was carried out in a 5 L bioreactor with 
agitation of 12 rpm (Figure 3). To determine biomass dry weight (g/L), pH and 
bacteriocin activity, samples were taken out before inoculation, and after inoculation 
following 24 hours of incubation. Bacteriocin activity of the cell-free culture 
supernatant was measured by bioassay.   
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 The supernatant of the fermentation was adsorbed in the sugarcane bagasse 
support, and the biomass was used as probiotic. This support impregnated with 
fermented broth was dried at 50°C in a ventilated oven.  
 
FIGURE 3 – Bioreactor BioTecnal –TE 2005, five-liter capacity. 
 
3.5.1. SUGAR CONTENT IN FERMENTATION PROCESS 
In the present work, Somogyi-Nelson method (Nelson, 1944; Somogyi, 1945) was 
employed to determine reducing sugars and, for the total sugars, the method employed 
was Phenol-Sulfuric acid (Dubois et al., 1956). 
  
3.6. ORGANIC ACIDS QUANTIFICATION IN FERMENTATION 
PROCESS 
 To quantify organic acids present in the lactic fermentation and in natural 
biopromoter the High Performance Liquid Chromatography (HPLC) method was used 
and its operating conditions are shown in table I.   
 
TABLE I – Operating conditions on HPLC to quantify organic acids in fermented 
products. 
Chromatography Operating conditions 
Column 
Column temperatura 
Amine x HPX 87H 
60 °C 
Mobile phase  – eluent H2SO4 
Mobile phase concentration 5 mM 
Mobile phase flow rate 0.6 mL/min 
Pressure pump 48 kg/cm2 
Injection volume 20 µL 
  
According to these conditions table II shows the retention times of each component. 
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TABLE II – Retention times of some organic acids on the HPLC column.  
Standard organic acid Retention time (min) 
Glucose 8.96 
Formic acid 13.33 
Lactic acid 12.65 
Acetic acid 14.78 
Ethanol 21.50 
 
3.7. ANTIMICROBIAL TEST - BIOASSAY 
 
3.7.1. Antimicrobian activity of the biopromotor 
 Plates with Agar Muller Hinton Broth were used for growing bacteria culture. 
Bacteria Escherichia coli ATCC 25922 were activated in BHI (Brain Heart Infusion) 
broth, and incubated at 37 ºC for 24 hours. After activation, they were diluted to 10-3 
with 0.1% peptone water.  This 10-3 dilution was spread out onto the surface of each 
agar plate using a sterile spatula and adding 50 mg of biopromotor /well. In another 
plate an antibiogram test using Neomycin stander antibiotic (NEO 30 MCG) was added 
onto the agar surface with biopromotor (50mg/well) followed by incubation at 37 °C for 
24 hours. HPLC was used to analysis of biopromotor concentration. After incubation, 
the diameter of the inhibition halo formed around the disk was measured.  
 
3.8. INCOME COEFICIENT AND KINETIC PARAMETERS IN THE 
BIOMASS OF Lactobacillus P01-001 
 The income coefficient of the biomass production of  Lactobacillus P01-001 was 
obtained through of the equation (1); the biomass productivity  for the equation (2) and 









=/  (1) 
Where: 
Xo = final biomass 
Xi = initial biomass 
Si = initial sugar 
So = final sugar 
 The biomass productivity was obtained by the following relation: 
 
XhLgPX .)./( µ=  (2) 
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Where: 
µ  = specific growth factor (h-1) 
X = final biomass (g/L) 
 
3.9. DEVELOPMENT OF THE NATURAL BIOPROMOTOR 
Several steps are necessary for developing the natural biopromoter, such as 
microorganism selection and fermentation. In the end of the lactic fermentation 
centrifugation (7.000 g at 4°C for 10 min) done in Falcon tubes, it was carried out to 
separate broth from the cells. 
The broth was separated to be adsorbed in the support, while the cells were 
rehydrated in 25% (v/v) of skimmed milk and kept frozen at -4°C, and afterwards these 
cells were lyophilized to obtain the Probiotic PP-LPB. The process of biopromoter and 
probiotic production are summarized in figure 6.  
 
 
Figure 6 – Bioprocess production of the probiotic and biopromoter. 
 
3.9.1. THE SUPPORT PREPARATION 
 The less fibrous internal part of the sugarcane was used because the adsorption is 
better in this portion.  The bagasse was washed three times and after dried at 70 °C it 
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was ground on knife mill and the product was passed through sieves with mesh from 6 
to 14. 
 
3.9.2. FERMENTED BROTH APPLICATION ON SUPPORT 
 The fermented broth was mixtured to the support by an air compressor 
connected to an injector pistol until it became saturated but without droplet formation, 
i.e., when it achieved around seven times of its initial weight. Additionally, it was 
observed that a support weighting 143g could adsorb approximately 1000mL of 
fermented broth. Therefore, each gram of biopromotor retained 7 mL in fermented broth 
that means 7 times more concentrate.  This way, for the amount of support available in 
the present work, the fermented broth volume used was 88 L (figure 4).  
 
FIGURE 4 – Trays containing the biopromotor and sugarcane bagasse support. 
 
3.9.3. BIOPROMOTOR ON DRYING TRAYS 
 Biopromotor was placed on trays and kept to dry at 50°C in a ventilated oven TE 
394/3 TECNAL for approximately five hours by each dry cycle. The trays were made of 
wood with dimensions 0.75m x 0.55m x 0.05m. A mesh 50-screen was attached to the 
bottom of each tray to allow the air circulation in between of the support more 
fermented broth.     
 
3.9.4.  ADSORPTION EVOLUTION OF SUGARCANE BAGASSE/BROTH 
FERMENTED 
 An experiment was realized to determine the saturation region and the 
adsorptive capacity of the support. Three grams of the support were adsorbed several 
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times with fermented broth and dried. After each cycle of adsorption and drying the 
support was weighed to determine the weight gain.  
 
3.9.5. BIOPROMOTOR PREPARATION  
The biopromotor was grounded several times in microniser (pin mill) until mesh 
30 granulometry powder was obtained. After micronisation the biopromotor was 
homogenized in shaped Y mixer.   
 
3.9.6. BIOPROMOTOR ORGANIC ACID ANALYSED BY HPLC 
  
 From the final biopromotor produced it was taken 1g and added to 9 mL of ultra 
pure water. After shaking in vortex, the sample was kept for 3 hours in the fridge for 
dissolution of the soluble composts present in the sample. The sample was filtered in 
sieve and diluted again to 1:10 proportion. Then, the diluted sample was filtered in 
0.22µm filter and injected on HPLC for organic acids analysis.      
 
3.10. BIOPROMOTER ANIMALS TEST 
 The effect of the probiotic and of the natural biopromoter was evaluated based 
on the animal performance of 25 days suckling pigs diet. 
3.10.1. Animals and Facilities 
Forty eight (48) suckling pigs with 25 days old were used, accommodates in a 
nursery pig with 12 suspended compartments (1,50 x 2.00 m each one). All suckling pig 
received enough feed and water and the same conditions of handle, as well as Ouro Fino 
Ivermectin 1%, in the beginning of the experiment. 
  
3.10.2.  Studied Variables 
The animal performance was studied based on the daily weight gain, daily feed 
consumption and feed conversions. The present work was divided into phases according 
to the age of the animals: phase 1 (25 to 35 days), phase 2 (35 to 54 days).  
 
3.10.3. Treatments 
The different treatments for the suckling pigs can be seen in the table III. The 
basal feed composition for the suckling pigs can be seen in annex 2. 
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TABLE III – Series of treatments given to suckling pigs. 
Treatments Description 
T1 Basal feed (Negative control) 
T2 Basal feed + Growth promoter1 (Positive control) 
T3 Basal feed + Probiotic PP-LPB 1,0% 
T4 Basal feed + Natural Biopromoter 0,50% 
1 Neomicin sulphate Ouro Fino®  (56 ppm)  
 
3.10.4. Statistics and Experimental Analysis 
The experimental analysis was in casual blocks (DBC) with 3 repetitions of 4 
animals each (two male and two female). The results were analysed by of the procedure 
“General Linear Model” (GLM) of the software “Statistical Analysis Sistem” (SAS- 
1998), and the averages compared with the Tukey test with 5% probability.  
  
3.11. ECONOMIC ANALYSIS OF THE BIOMASS PRODUCTION OF 
Lactobacillus P01-001 IN ALTERNATIVE MEDIUM 
 The comparison between medium for biomass production was realized using a 
commercial medium culture MRS (DifcoTM Lactobacilli) and an alternative medium in 
brown sugar 3% and yeast extract 1%. The economic analysis was performed to 
produce 1 g/L of biomass: 
• To prepare 1 liter of  MRS broth it costs $ 19.80 
• To prepare 1 liter of alternative medium (brown sugar 3% and yeast extract 




4.1. MICROORGANISM ISOLATION 
 
 Thirty three strains were isolated after tolerance tests to extreme temperatures, 
different pH concentrations, and bile, an inhibitory substance. Three strains were 
selected (P01-001, P08-002 and LPB-05) since they presented the following 
characteristics: bacillary bacteria, Gram positive and strong viability during the process. 
The isolates P01-001 showed the best viability compared to the others. 
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4.2. MORPHOLOGICAL, BIOCHEMICAL AND PHYSIOLOGICAL 
CHARACTERISTICS 
 
4.2.1. Morphology and Physiology in Optical Microscope 
The isolates are slightly irregular in shape, similar to bacillus form separated or 
linked in chain, generally present dimensions with width 0.7-1.0µm and length 2.0-
5.0µm (Figure 5). These bacteria are heterofermentatives by producing other 
metabolites such as lactic acid, acetic acid, propionic acid, formic acid and ethanol.  
Therefore, according to these aforementioned characteristics, they can be considered as 
lactic bacteria. 
 
FIGURE 5 – Isolate P01-001 morphology viewed by optical microscope (400x). 
 
4.2.2. Sugar Fermentation  
According to the gallery API 50 CHL (Biomérieux) of sugar fermentation, the 
isolates P01-001 and P08-002 were identified as Lactobacillus fermentum with 
probability 95%. As for the isolate LPB-05, it was identified as L. acidophilus. 
  
4.3. MOLECULAR CHARACTERIZATION 
 In the present work, the obtained isolates (P01-001, P08-002 e LPB-05) were 
genetically compared to reference standard strains (Table IV) by analyzing the 
electrophoretic profile of amplified DNA fragments using RAPD-PCR technique. The 
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outcome of screening test showed that informative patterns were obtained with M14 and 
COC primers, already applied for typing in several microorganisms (Paffeti et al., 1995, 
Zaparolli et al., 2000, Torriani et al., 2001). However, in this study the M14 primer did 
not show difference between Leuconostoc and L. sakei (figure 6). In addition, by using 
M13 primer no difference was seen between P01-001 and P08-002, but difference was 
detected when A3 primer was used (annex 1). 
 
TABLE IV – List of standard strains and isolated strains including the individual enter 
codes of the stock banks. 
SPECIES CODE 
Lactobacillus alimentarius ATCC 29643 
Lactobacillus curvatus ATCC 514369 
Lactobacillus casei shirota YIT – 9018 
Leuconostoc mesenteroides INRA 23 
Lactobacillus lactis INRA 18 
Lactobacillus sakei ATCC 15521 
Lactobacillus fermentum ? P01-001 
Lactobacillus fermentum ? P08-002 
Lactobacillus fermentum ? P01-001 05 
Lactobacillus fermentum ATCC 9338 




FIGURE 6 – Agarose gel electrophoresis showing amplified DNA using M13 and M14 
primers in RAPD-PCR technique.  
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 The philogenetic relation among the isolates and the reference strains can be 
observed by the built dendogram in figure 7.     
 
FIGURE 7 – UPGMA dendogram derived from the combined patterns using seven 
primers (A2, A3, A9, A10, COC, M13 and M14. Five groups were indicated: I, 
Leuconostoc mesenteroides group, II, L. casei group, III, strains P01-001, P08-002, IV, 
L. acidophilus and L. fermentum, and V, L. curvatus. 
 
 The isolated strains (P01-001, P08-002 and LPB-05) showed according to their 
profiles a clear separation from the reference strains. Although RAPD-PCR technique 
has not shown homology to ATCC 9338 strain, the L. P01-001 strain was identified as 
being L. fermentum by biochemical characterization. By RAPD-PCR technique this 
strain forms a separated cluster. Both isolated L. P01-001 and P08-002 strains presented 
a coefficient of similarity equal to 0.62. It was observed 46% of genetic similarity 
between LPB-05 and the strains YIT-9018, ATCC 15521 and INRA 18. Five distinct 
clusters where obtained in the present work. Cluster I include Leuconostoc 
mesenteroides group, cluster II, L. casei shirota group, cluster III, P01-001 and P08-002 
strains, cluster IV, L. acidophilus and L. fermentum, and cluster V includes  L. curvatus. 
 The importance of the molecular approaches to identify bacterial strains goes 
beyond of the classical morphology, biochemistry or physiology, so that, this approach 
might play a pivotal role in the understanding about genetic relations among bacterial 
strains, principally those of industrial interest. Several authors have used RAPD-PCR or 
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others molecular methodologies to study genetic diversity of Lactobacillus spp. Using 
specific amplification of 16S Ribosomal DNA, Heilig et al. (2001) studied the diversity 
of Lactobacillus group from fecal samples and found that molecular approaches were a 
strong tool to show genetic diversity of lactobacilli in the human GI tract. Torriani et al 
(2001) had used RAPD-PCR method in their work and concluded that this technique 
allowed distinguishing genetic variability in intra-specific level. 
In our study, molecular methods have established a great genetic diversity 
among isolated strains, which was not possible to evidence through morphological and 
biochemical studies. 
 
4.4. ADSORPTION OF THE FERMENTED BROTH IN THE SUGARCANE 
BAGASSE SUPPORT 
The adsorption of sugarcane bagasse support by fermented broth and its 
maximum saturation capacity were evaluated in the present work.  It was observed that 
initially the support adsorbs around 7 times of its weight.  
The relation between adsorbed volume and the weight gained by the support 
after each adsorption step is shown in figure 10. It was observed that after 33 cycles of 
adsorption, 3g of support could achieve 13.41g.  The total volume adsorbed was 438ml 
of fermented broth.  After 12 adsorption cycles, the support looses adsorptive capacity 
and the increasing in volume are lesser in each new cycle. Thus, the saturation starts 
with 12 cycles of adsorption. Moreover, it was possible to observe that after six cycles 
of adsorption the support weight duplicates and after 12 cycles it triplicates. It is 
important to notice that for this experiment the condition given to support was the same 
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FIGURE 9 – Linear relation between volume and weight gained by support.  
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4.5. ORGANIC ACID AND BIOPROMOTER QUANTIFICATION IN THE 
FERMENTATION PROCESS 
 The strain Lactobacillus P01-001 produces several organic acids such as lactic 
acid, formic acid acetic acid, propionic acid and ethanol.  The concentrations of glucose 
and organic acids are presented in table V.  
 
Table V – Glucose and organic acids concentrations in the fermentation broth after 24h 
and in the biopromoter product. 
HPLC sample Fermentation broth 24h 
Concentration (% w/w) 
Biopromoter Feed 
(% w/1g of biopromoter)  
Glucose 8.51 59.02 
Lactic acid 33.84 13.33 
Formic acid - 7.06 
Acetic acid 19.93 10.87 
Propionic acid 9.93 9.70 
Ethanol  15.45 - 
 
In this research, the chromatographic profile of the organic acids presents in the 
fermented broth was similar to that obtained by Pancheniak (2005). One gram of 
biopromoter adsorbed 6.99 ml of fermented broth. However, since 50°C is the 
temperature kept during the dry cycles, there is a possibility that some of these organic 
acids may evaporate or degrade.        
   
4.6. ANTIMICROBIAL ACTIVITY OF THE BIOPROMOTER 
The zone of biopromoter inhibition can be observed in figure 10a. Table VI 
shows the diameter of each clear halo that represents the zone of inhibition. It was 
observed that increase in biopromoter concentration (adsorption) leads to increase in 
the inhibition zone reflected by the enhancement in diameter. Comparison between 
the clear halo formed by biopromoter and Neomicin (30MCG) treatment can be seen 
on figure 10b. The clear zone of inhibition formed to the biopromoter was 13.0 mm 
while the zone of inhibition formed to the antibiotic was 18.0 mm. It was verified that 
inhibition capacity is higher in the biopromoter however similar to that found for the 
commercial promoter Neomycin. It is clear from this result that the biopromoter is a 
bacteriostatic and not bactericidal. Then, it may be concluded that the biopromoter is 
highly effective antimicrobial agent against Escherichia coli ATCC 25922. 
 
 28 
TABLE VI – Antimicrobial activity of the biopromoter against the bacteria Escherichia 
coli ATCC 25922. 
Adsorption number Clear zone of inhibition diameter (mm) 
Sugarcane bagasse - 
Biopromoter  13.03 
 
 (a)  (b) 
FIGURE 10 – (a) The clear zone of inhibition against the bacteria Escherichia coli 
hemolítica. (b) Comparison of the inhibitory effect of the biopromoter with Neomicin. 
 
4.1. MODELING OF THE BACTERIAL GROWTH 
The model for bacteria growing developed in the present work was based on the 
growth kinetic and the substrate consumption analysis.  The growth kinetic results were 
given in g/l (figure 11). The values obtained to µ (h-1), PX (g/L.h) and YX/S are shown on 
table VII. 
Ln biomass vs Time









T ime ( h)
 
FIGURE 11 – Growth kinetic of Lactobacillus P01-001 in bioreactor. The medium 
composition was 3% of brown sugar and 1% of yeast extract. 
 
The growth kinetic and substrate consumption data are plotted on figure 12. 
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FIGURE 12 – Growth kinetic of Lactobacillus P01-001 and the substrate consumption. 
The medium composition was 3% of brown sugar and 1% of yeast extract. 
   
TABLE VII – Specific growth speed (µ), biomass production (PX), and yield (YX/S), 
during eight hours of growth.   
Coeficients Values 
µ (h-1) 0.2017 
PX (g/L.h) 0.348  
YX/S 0.198 
 
This kinetic economic model shows that the fermentation can be stopped after 
10 hours of culture. It is observed in figure 12 an excess of sugar. The explanation is 
that the analysis takes into account the total sugars and it is worth noticing that the 
microorganism is able to consume only reducer sugars such as glucose and fructose, 
present in the brown sugar in the proportion of 1.5%. The larger percentage available is 
sucrose, however, it is not immediately ready for microorganisms consumption. 
 
4.2.   BIOPROMOTER ANIMALS TEST 
The first week after weaning is considered the most risky phase for piglets. The 
change from a high nutritive liquid meal (milk) to a solid feed with different digestible 
proteins that can cause to piglets frequent digestive disturbs. 
 In the present work, results obtained in this phase did not show significant 
difference among the piglets, however it was noticed for the daily weight gain (DWG) a 
difference in 50g more for the positive control related to the negative control (Figure 
13). In addition, a reduction in feed conversion in 9.5% was also observed, which 
indicates the effect of the promoter in the animals growth (Figure14). When daily 
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weight gain (DWG) was compared between animals treated with the Probiotic PP-LPB 
and with the natural Biopromotor related to the negative control. It was noticed that half 
of the effects was attributed to the growth Promoter, although the feed conversions were 
small showing 11.17 and 16.76% respectively. 
 In the second part of this assay, the feed conversion of the piglets that received 
the natural Biopromoter was significantly smaller than the negative and positive 
controls. Probiotic was in an intermediate level. In this phase, the growth Promoter did 
not result in improvement of the studied rates.  
In a general analysis of both phases it was verified an increase in feed 
consumption on animals treated with Biopromotor (Figure 15). However, concerning 
the weight gain and food conversion for animals treated with Probiotic, the results were 
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FIGURE 15 – Feed consumption from piglets by treatment. 
 
4.3. ECONOMIC ANALYSIS OF BIOMASS PRODUCTION OF 
Lactobacillus P01-001 IN ALTERNATIVE MEDIUM 
 
The cost of biomass production comparisons were carried out using a commercial 
medium culture MRS (DifcoTM Lactobacilli) and a alternative medium based on brown 
sugar 3% and yeast extract 1% (TABLE VIII). The economic analysis was performed 
for 1 g/l of biomass production taking into account the following values: 
• To prepare 1 litter of MRS broth it costs $ 19.80 
• To prepare 1 litter of alternative medium (brown sugar 3% and yeast extract 
1%) it costs $ 0.28 
 
TABLE VIII – Economical comparison of biomass production in alternative medium. 
Composition  Dry weight (g/L) Production cost 1 g/L (R$)  
MRS broth 1.348 36.72 
Alternative broth  1.73 0.40 
 
 The formulation in alternative medium is much more efficient than the 
commercial MRS broth. The alternative medium can become incredibly cheaper when 





5. CONCLUSION  
 
Five distinct clusters were obtained by RAPD-PCR technique and the isolated 
strain bacteria from swine used in this study was included into L. fermetum cluster. 
However, the similarity coefficient in this cluster is only 35%. 
This strain is a potential probiotic bacterium because it can resist under high bile 
concentrations and produce organic acids and bacteriocins. Therefore, it is effective in 
the animal improvement, as it was observed in the present study concerning the given 
concentration. L. P01-001 is a heterofermentative bacterium, with microaerophilic 
characteristic.   
The fermented broth used in the natural biopromoter showed similar effect 
against Escherichia coli ATCC 25922 compared to the growth promoter Neomycin (30 
MCG) concerning the formation of the inhibition halo. 
The biopromoter tested in animals showed improvement in the zootecnic rates, 
daily weight gain, daily feed consumption and feed conversion, for the used dosage.  
 In the diet of the suckling pigs, the biopromoter can be used as growth promoter 
in substitution of the antibiotic Neomycin. Since the biopromoter is a natural composite, 
it follows the rules for antibiotic controls from Department of Agriculture making 
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List of primers used in the RAPD reaction for identification of Lactobacillus isolates. 
Primers Sequence 5’-3’ No. Bases %C+G 
M13 GAGGGTGGCGGTTCT 15 66.7 
M14 GAGGGTGGGGCCGTT 15 73,3 
COC  AGCAGCGTGG 10 70 
A2                                  TGCCGAGCTG   10 70 
A3                                  AGTCAGCCAC 10 60 
A9                                                                           GGGTAACGCC 10 70 
A10                                                                           GTGATCGCAG 10 60 
 
 
Components of the reaction DNA amplification of Lactobacillus and concentration used 
in the RAPD reaction for primers A2, A3, A9 and A10. 
Components Concentration Reaction volume 
(µL) 
Milli-Q water --- 18.25 
Buffer 10X 2.5 
DNTP MIX 5 mM 1.0 
Primer 10 µM 1.0 
MgCl2 50 mM 0.75 
Taq polimerase 5 U/µL 0.5 
DNA --- 1.0 
Total --- 25.0 
 
 
Components of the reaction DNA amplification of Lactobacillus and concentration used 
in the RAPD reaction for primers M13 and M14. 
Components Concentration Reaction volume 
(µL) 
Milli-Q water --- 18.1 
Buffer 10X 3.0 
DNTP MIX 5 mM 1.2 
Primer 10 µM 1.2 
MgCl2 50 mM 4.0 
Taq polimerase 5 U/µL 0.5 
DNA --- 2.0 




Components of the reaction DNA amplification of Lactobacillus and concentration used 
in the RAPD reaction for the primer COC. 
Components Concentration Reaction volume 
(µL) 
Milli-Q water --- 40.1 
Buffer 10X 6.0 
DNTP MIX 5 mM 1.2 
Primer 10 µM 1.2 
MgCl2 50 mM 7.0 
Taq polimerase 5 U/µL 0.5 
DNA --- 4.0 
Total --- 60.0 
 
Conditions of amplification for the different primers. 
Cycle number Primer M13 e M14 
Temperature./Time 




1 cycle 94º.C / 2min. 94º.C / 5min. 94º.C / 2min. 
94º.C / 1min. 94º.C / 1min. 94º.C / 1min. 
29º.C / 1min. 36º.C / 1min. 45º.C / 20seg.. 





72º.C / 2 min. 72º.C / 2 min. 72º.C / 2 min. 
1 cycle 72º.C/ 5min. 72º.C/ 7min. 72º.C/ 10min. 
 
RAPD  profile obtained for amplification with primer A3.    
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RAPD  profile obtained for amplification with primer A9.       
 








List of feed composition for the suckling pigs.  
 
Feed composition 
Ingredients Pre-start Start 
Corn 48.336 57.49 
Defatted soybean cake 26.105 30.61 
Lactic product 20.00 3.00 
Sugar - 2.00 
Dicalcium fosphate 2.178 0.267 
Calcarium 0.468 0.781 
Inert 2.00 1.50 
Soy oil - 1.00 
Antioxidant 0.010 - 
Metionin 0.312 0.100 
Lisin 0.236 0.077 
Treonin 0.068 0.045 
Sodium chloride 0.156 - 
Supplement Min/Vit1 0.100 - 
Supplement Min/Vit2 - 3.13 
Total 100.00  
Composition 
Brute Protein (%) 21.00 19.00 
Digestive Energy (kcal/kg) 3411.0 3336.0 
Lactose (%) 8.00 1.200 
Calcium (%) 0.900 0.840 
Available Phosphorus (%) 0.500 0.440 
Sodium (%) 0.220 0.180 
Metionin (%) 0.629 0.396 
Metionin + Cistin (%) 0.810 0.650 
Lisin (%) 1.360 1.200 
Treonin (%) 0.910 0.790 
Triptophan (%) 0.279 0.250 
1 Mineral and vitaminic supplement without growth promoter. To guarantee levels for 
Kg of feed: Vit. A – 4.000 U.I.; Vit. D3 – 220 UI.; Vit. E – 22 mg; Vit. K – 0,5 mg; Vit. 
B2 – 3,75 mg; Vit. B12 – 20 mcg; Calcium Pantotenate – 12 mg; Niacin – 20 mg; Colin 
– 60 mg; Iodine – 140 µg; Selenium – 300 µg; Manganese – 10 mg; Zinc – 100 mg; 
Cupper – 10 mg; Iron – 99 mg. 
2 Given for pigs in initial phase. 
 
